{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:27:56Z","timestamp":1762475276927,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jdcr.2021.07.013","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T22:46:46Z","timestamp":1627512406000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Complete remission of intractable bullous erythema multiforme with thalidomide therapy: A case series"],"prefix":"10.1016","volume":"15","author":[{"given":"Tian Ran","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Nadelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdcr.2021.07.013_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"3","key":"10.1016\/j.jdcr.2021.07.013_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.det.2010.03.003","article-title":"Innovative uses of thalidomide","volume":"28","author":"Chen","year":"2010","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jdcr.2021.07.013_bib3","first-page":"78","article-title":"Oral presentation and management of vesiculobullous disorders","volume":"13","author":"Siegel","year":"1994","journal-title":"Semin Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.07.013_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","article-title":"Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2021.07.013_bib5","first-page":"e3459","article-title":"Variants of erythema multiforme: a case report and literature review","volume":"10","author":"Paulino","year":"2018","journal-title":"Cureus"},{"issue":"9423","key":"10.1016\/j.jdcr.2021.07.013_bib6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jdcr.2021.07.013_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.lpm.2016.01.005","article-title":"Aphthous ulcers and oral ulcerations.\u00a0Article in French","volume":"45","author":"Vaillant","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.jdcr.2021.07.013_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320916023","article-title":"Successful treatment with thalidomide for pemphigus vulgaris","volume":"11","author":"Zhang","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"suppl 2","key":"10.1016\/j.jdcr.2021.07.013_bib9","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1067\/mjd.2002.109255","article-title":"Thalidomide therapy for cicatricial pemphigoid","volume":"47","author":"Duong","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2021.07.013_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2183\/pjab.96.016","article-title":"Molecular mechanisms of thalidomide and its derivatives","volume":"96","author":"Ito","year":"2020","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"12","key":"10.1016\/j.jdcr.2021.07.013_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1248\/yakushi.19-00181-3","article-title":"Mechanisms of severe cutaneous adverse reactions and a new treatment strategy. Article in Japanese","volume":"139","author":"Saito","year":"2019","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"10.1016\/j.jdcr.2021.07.013_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.jdcr.2021.07.013_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D35FK5W0QV","article-title":"A review of thalidomide's history and current dermatological applications","volume":"9","author":"Perri","year":"2003","journal-title":"Dermatol Online J"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100494X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100494X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:23:11Z","timestamp":1762474991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262100494X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":13,"alternative-id":["S235251262100494X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.013","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete remission of intractable bullous erythema multiforme with thalidomide therapy: A case series","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}